Quantcast

Latest Prostate cancer Stories

2014-03-28 23:22:33

Two recent studies illustrate the danger of smoking, especially among diabetics who take insulin. Raleigh, NC (PRWEB) March 28, 2014 New research studies conducted in Taiwan and Turkey and reported by Cancer Monthly show that the risk of bladder cancer is exacerbated by smoking. The risk was even higher among diabetics who were on insulin. Evidence suggests that people with type 2 diabetes face a higher risk of bladder cancer than the general public (“Bladder Cancer and diabetes,”...

2014-03-27 12:31:28

Preventive services like HPV vaccination and colorectal cancer screening are important tools in reducing cancer rates ATLANTA, March 27, 2014 /PRNewswire-USNewswire/ -- Rates of invasive cancer cases among U.S. men and women dropped slightly from 459 per 100,000 persons in 2009 to 446 per 100,000 persons in 2010, according to a study by the Centers for Disease Control and Prevention. The highest rates were for prostate, female breast, lung and bronchus, and colon and rectum cancers, which...

2014-03-27 08:34:30

BETHESDA, Md., March 27, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for cancer, announced today that Linda Powers, CEO, will present at the 4(th) Annual "Cancer Immunotherapy: A Long-Awaited Reality" conference being held at the New York Academy of Medicine in New York City on Thursday, March 27 at 2:45 pm ET. During her presentation, Ms. Powers will provide an...

2014-03-27 08:33:33

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/djkgl4/therapeutic_class ) has announced the addition of the "Therapeutic Class Overview: Newer Oral Anti Androgens - Expanding Role in the Treatment Paradigm of Prostate Cancer" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) In recent past approval and launch of various newer treatment options like Xtandi (Enzalutamide,...

2014-03-26 23:26:31

A report to the nation’s bladder cancer specialists says more of them should be taking a multidisciplinary approach to treating their patients with bladder cancer. Raleigh, NC (PRWEB) March 26, 2014 Researchers say treating the invasive form of bladder cancer with both surgery and chemotherapy can improve survival, especially if chemotherapy is delivered prior to surgery. Click here to see details of the new report, which has just been posted by Cancer Monthly. In a report presented at...

2014-03-26 16:24:58

DALLAS, March 26, 2014 /PRNewswire-iReach/ -- RnRMarketResearch.com adds "Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global" to its store that says Cancer testing has tremendous growth opportunities for the next five years. (Photo: http://photos.prnewswire.com/prnh/20140326/MN91058) Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year...

2014-03-26 08:29:17

ARDEN HILLS, Minn., March 26, 2014 /PRNewswire-iReach/ -- Galil Medical, the global leader in interventional oncology cryotherapy treatments, announced the launch of its latest prospective clinical research study, SOLSTICE (Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation). Photo - http://photos.prnewswire.com/prnh/20140326/MN90636 The SOLSTICE Clinical Study is the largest multi-center prospective trial focused on the...

2014-03-24 23:00:59

Understanding bone health is critical for advanced stage prostate cancer patients. Malecare Cancer Support is presenting a free teleconference for prostate cancer patients and their families with noted urologist Neil Shore, MD. New York, NY (PRWEB) March 24, 2014 Malecare Prostate Cancer Support will present a teleconference titled, "Bone Health and Prostate Cancer.” The conference is scheduled for Tuesday, March 25, 2014 at 6PM ET. The teleconference is available without cost and...

2014-03-24 16:24:53

TOKYO, March 24, 2014 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) today announced that Astellas has obtained marketing approval of their oral androgen receptor signaling inhibitor, XTANDI(®) capsules 40mg (development code: MDV3100; generic name: enzalutamide) for the treatment of patients with castration-resistant prostate cancer in Japan. Astellas filed the application for approval in Japan in May 2013. XTANDI is a once-daily, oral androgen receptor signaling inhibitor that acts on...

2014-03-24 16:22:35

NORWALK, Conn., March 24, 2014 /PRNewswire/ -- UBM Medica US announces that Cancer Network, the online home of the journal ONCOLOGY presents a special report on the most prevalent cancer for men, prostate cancer. Cancer Network, a leading online community for oncologists and others who treat cancer, offers news, blogs, and podcasts about the latest clinical findings and best practices in oncology. As part of our special series on prostate cancer, we present: -- An interview with...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related